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STUDY QUESTION: Can novel meiotic RNA targets of DAZL (deleted in azoospermia-like) be identiﬁed in the human foetal ovary?
SUMMARY ANSWER: SYCP1 (synaptonemal complex protein-1), TEX11 (testis expressed 11) and SMC1B (structural maintenance of
chromosomes 1B) are novel DAZL targets in the human foetal ovary, thus DAZL may have previously unrecognised roles in the translational
regulation of RNAs involved in chromosome cohesion and DNA recombination in the oocyte from the time of initiation of meiosis.
WHAT IS KNOWN ALREADY: The phenotype of Dazl deﬁciency in mouse is infertility in both sexes and DAZL has also been linked to
infertility in humans. Few studies have explored targets of this RNA-binding protein. The majority of these investigations have been carried
out in mouse, and have focussed on the male thus the basis for its central function in regulating female fertility is largely unknown.
STUDY DESIGN SIZE, DURATION: We carried out RNA sequencing after immunoprecipitation of endogenous DAZL from human
foetal ovarian tissue (17 weeks of gestation, obtained after elective termination of pregnancy) to identify novel DAZL targets involved in meiosis
(n = 3 biological replicates).
PARTICIPANTS/MATERIALS, SETTING, METHODS: Using quantitative RT-PCR, we examined the expression of selected RNAs
identiﬁed by our immunoprecipitation across gestation, and visualised the expression of potential target SMC1B in relation to DAZL, with a
combination of in situ hybridisation and immunohistochemistry. 3′ untranslated region (3′UTR)-luciferase reporter assays and polysome pro-
ﬁle analysis were used to investigate the regulation of three RNA targets by DAZL, representing key functionalities: SYCP1, TEX11 and
SMC1B.
MAIN RESULTS AND THE ROLE OF CHANCE: We identiﬁed 764 potential RNA targets of DAZL in the human foetal ovary (false
discovery rate 0.05 and log-fold change≥ 2), with functions in synaptonemal complex formation (SYCP1, SYCP3), cohesin formation (SMC1B,
RAD21), spindle assembly checkpoint (MAD2L1, TRIP13) and recombination and DNA repair (HORMAD1, TRIP13, TEX11, RAD18, RAD51).
We demonstrated that the translation of novel targets SYCP1 (P = 0.004), TEX11 (P = 0.004) and SMC1B (P = 0.002) is stimulated by the
presence of DAZL but not by a mutant DAZL with impaired RNA-binding activity.
LARGE SCALE DATA: The raw data are available at GEO using the study ID: GSE81524.
LIMITATIONS, REASONS FOR CAUTION: This analysis is based on identiﬁcation of DAZL targets at the time when meiosis starts in
the ovary: it may have other targets at other stages of oocyte development, and in the testis. Representative targets were validated, but
detailed analysis was not performed on the majority of putative targets.
WIDER IMPLICATIONS OF THE FINDINGS: These data indicate roles for DAZL in the regulation of several key functions in human
oocytes. Through the translational regulation of novel RNA targets SMC1B and TEX11, DAZL may have a key role in regulating chromosome
cohesion and DNA recombination; two processes fundamental in determining oocyte quality and whose establishment in foetal life may sup-
port lifelong fertility.
© The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits
non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
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G1100357 to R.A.A. and an intramural MRC programme grant to I.R.A.). The authors declare no competing interests.
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Introduction
DAZL (deleted in azoospermia-like) and its homologues DAZ
(deleted in azoospermia) and BOLL (bol-like RNA-binding protein)
comprise a family of RNA-binding proteins that have essential roles in
gametogenesis. DAZ gene expression is only found in humans and Old
World monkeys; transcription is limited to the male germline (Ruggiu
and Cooke, 1999) and DAZ is deleted in 12–15% of azoospermic men
(Reijo et al., 1995). In all other vertebrates, DAZ is replaced by an
autosomal single-copy gene: DAZ-like (DAZL). Targeted disruption of
Dazl in mice results in infertility in both males and females (Ruggiu
et al., 1997; Saunders et al., 2003) and in the human DAZL is expressed
in germ cells in ovary and testis in both foetal and adult life
(Habermann et al., 1998; Dorfman et al., 1999; Anderson et al., 2007).
Polymorphisms in the promoter and coding sequence of DAZL have
been correlated with total sperm count and sperm motility in infertile
men (Teng et al., 2002; Tung et al., 2006a), while altered methylation of
the DAZL promoter has been associated with male infertility (Navarro-
Costa et al., 2010; Li et al., 2013). In women, however, there has been
only one report concerning the relevance of DAZL to fertility, with poly-
morphisms in DAZL shown to inﬂuence the age at premature ovarian
insufﬁciency and menopause (Tung et al., 2006a); however, this has not
been reported in other studies (Bartoloni et al., 2004; Zerbetto et al.,
2008). These observations suggest that hypomorphic polymorphisms
and single nucleotide polymorphisms that quantitatively reduce DAZL
expression or function in human germ cells could potentially have conse-
quences for fertility and reproductive lifespan in women.
Deletion of Dazl in mice causes loss of germ cells in the gonads of
both sexes, with increased apoptosis, reduced expression of germ-cell
markers and aberrant chromatin structure (Ruggiu et al., 1997;
Schrans-Stassen et al., 2001; Lin and Page, 2005). Dazl null mice also
have a reduction in the number of post-migratory primordial germ
cells, and germ cells fail to sexually differentiate and properly erase
genomic methylation imprints (Haston et al., 2009; Gill et al., 2011).
Of the few cells that are able enter meiosis, none are able to proceed
beyond leptotene of Prophase I, as complete synaptonemal complexes
fail to form in Dazl−/− mice, thus giving a precise point beyond which
meiosis cannot progress without Dazl (Saunders et al., 2003).
Furthermore, germ cells fail to induce the expression of meiotic genes
in response to retinoic acid (Lin and Page, 2005). Dazl deﬁciency spe-
ciﬁcally compromises germ-cell function, as the transplantation of
ROSA/LacZ-labelled spermatogonia into the testes of Dazl−/− mice
conﬁrms that the somatic tissues are capable of supporting gamete
development (Rilianawati et al., 2003).
DAZL acts post-transcriptionally, as demonstrated by its association
with actively translating polysomes (Tsui et al., 2000b) and its ability to
activate translation of bound mRNAs (Collier et al., 2005). The
involvement of DAZL in translational control is key for gametogenesis.
During their growth phase, mammalian oocytes are transcriptionally
active, however, mRNA synthesis drops to very low or undetectable
levels at the onset of meiosis (Clarke, 2012). From this point onwards,
gene expression in the oocyte and subsequent protein production is
highly dependent upon a well-orchestrated programme of dynamic
modulation of mRNA poly(A)-tail length, recruitment to polysomes
and translational activation or repression (Seydoux and Braun, 2006;
Radford et al., 2008). However, in order to understand the growing
spectrum of processes in gametogenesis that this gene may be
involved in, a knowledge of DAZL mRNA targets is required. Efforts
to uncover in vivo mRNA targets of mammalian DAZL have mainly
been focussed on mouse, and the male. Analysis of gene expression in
the Dazl−/− mouse foetal ovary has identiﬁed mRNAs whose abun-
dance is downstream of Dazl function, but this analysis does not iden-
tify mRNAs which are directly regulated by Dazl (Soh et al., 2015).
Three direct mRNA targets of Dazl characterised in vivo are Sycp3
(synaptonemal complex protein 3), Mvh (mouse vasa homologue)
(formally known as Ddx4 or Vasa) and Tex19.1 (testis expressed 19.1)
(Reynolds et al., 2005; Reynolds et al., 2007; Chen et al., 2011), and
Tet1 (tet methylcytosine dioxygenase 1) has also been demonstrated
to be dependent on Dazl for its translation in cultured mouse embry-
onic stem cells (Welling et al., 2015). Sycp3-deﬁcient spermatocytes
arrest in meiosis due to defects in chromosome synapsis, as do sper-
matocytes from Mvh and Tex19.1 null males (Tanaka et al., 2000;
Ollinger et al., 2008). This is a similar point at which meiotic progres-
sion ceases in male mice lacking Dazl (Lin and Page, 2005). This would
suggest that a loss or reduced expression of these genes, and possibly
also additional transcripts that are dependent on Dazl for their transla-
tion, contributes to the infertility phenotype observed in Dazl null male
mice. In contrast, whereas Dazl null female mice also arrest meiotic
progression in early prophase during foetal development (Saunders
et al., 2003), neither Sycp3, Mvh nor Tex19.1 null female mice have such
severe defects that oogenesis arrests at this stage (Tanaka et al., 2000;
Yuan et al., 2002; Ollinger et al., 2008). Additionally, currently unknown
Dazl targets in foetal oocytes may therefore be contributing to the Dazl
null phenotype in female mice. In humans, even less is known about
DAZL targets and their impact on female fertility (Rosario et al., 2016).
Here we identify novel RNA targets of DAZL in the human ovary,
using foetal tissue to allow analysis during the onset and early stages of
Meiosis I. Our data conﬁrm the meiotic role of DAZL in the human
foetal ovary, and also reveal novel potential functions for DAZL
through translational regulation of RNA targets involved in establish-
ment of chromosome cohesion and DNA recombination during early
meiosis in the foetal oocyte, key pathways implicated in the determin-
ation of lifelong oocyte quality.
Materials andMethods
Ethics statement
Ethical approval for this study was obtained from Lothian Research Ethics
Committee (study code LREC 08/S1101/1), and women gave informed
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written consent. Experiments involving mice were approved by the University
of Edinburgh Animal Research Ethics Committee and performed according to
the UK Animal (Scientiﬁc Procedures) Act 1986.
Collection of human foetal ovaries
Human fetuses (8–20 weeks gestational age (wga)) were obtained after
elective termination of pregnancy, and all fetuses used in this study were
morphologically normal. Gestational age was determined by ultrasound
scan, and conﬁrmed (for second trimester fetuses) by direct measurement
of foot length. The sex of ﬁrst trimester foetal gonads was determined by
PCR for the SRY gene (Childs and Anderson, 2012). Extra-ovarian tissue
was removed from dissected ovaries, which were then either snap frozen
on dry ice and stored at −80°C for subsequent RNA extraction, or ﬁxed
in Bouins or 4% neutral buffered formalin for 2–3 h before processing into
parafﬁn blocks for immunohistochemical analysis. Thirty-two foetal ovarian
samples were obtained and used in this study.
RNA immunoprecipitation
RNA immunoprecipitation was carried out using the Magna RIP™ Kit
(Millipore, Livingstone, UK) according to manufacturer’s instructions.
Immunoprecipitations were performed in lysates made from 2 homoge-
nised 17-week human foetal ovaries, from different fetuses. Separate
lysates were made for 3 biological replicates, thus 12 ovaries from a total
of 6 fetuses were used for these experiments. RNA–protein complexes
were immunoprecipitated using an antibody against human DAZL (dilution
1:100) (#8042, Cell Signalling Technology, Leiden, The Netherlands) (see
Supplementary Fig. S1 for antibody validation) or a control matched-IgG.
Following RNA puriﬁcation, the Ovation® RNA-Seq system V2 (NuGEN,
The Netherlands) was utilised to generate sufﬁcient quantities of oligo-T
primed cDNA (average size 350 bp), which was then subjected to paired-
end RNA sequencing using the Illumina HiSeq platform, performed by
Edinburgh Genomics, University of Edinburgh, UK. Paired-end sequencing
data were processed using TrimGalore v0.4.1 (http://www.bioinformatics.
babraham.ac.uk/projects/trim_galore/) to remove the CTTTGTGTTTGA
Ovation RNA-Seq adapter using—stringency 5 and—length 30 command
line parameters, then mapped to the hg19 assembly of the human genome
and Ensembl transcriptome using Tophat v2.1.0 (http://ccb.jhu.edu/
software/tophat) with command line parameters-g 1—mate-inner-dist
260—mate-std-dev 110—no-coverage-search—b2-sensitive. Mapped
reads that were primary alignments and overlapped Ensembl transcript co-
ordinates were counted using Bedtools intersect v2.25.0 (https://github.
com/arq5x/bedtools) in-split mode. Paired reads that mapped within the
same transcript were counted as a single read. Read counts were imported
into R v3.3.2 (https://www.r-project.org/) and biomaRt v2.30.0 (https://
bioconductor.org/packages/release/bioc/html/biomaRt.html) used to
map Ensembl transcripts to Ensembl genes using the Homo sapiens
GRCh38.p7 data set. Genes with multiple transcripts were collapsed into
the transcript containing the most read counts, the total number of reads
mapped to Ensembl genes counted. Low abundance genes containing few-
er than one count per million mapped reads in at least three samples were
discarded. Differential analysis was performed using DESeq2 v1.14.0
(https://bioconductor.org/packages/release/bioc/html/DESeq2.html)
using the biological replicate as a blocking factor in the design model to
identify differences between control and DAZL immunoprecipitations.
False discovery rate (FDR)-adjusted P-values of ≤0.05 were considered signiﬁ-
cant, and genes signiﬁcantly enriched more than 4-fold in DAZL relative to con-
trol immunoprecipitations were considered DAZL targets. This was ﬁltered
further to include only Ensembl genes with an HGNC gene symbol in the
bioMart database. Relationships between signiﬁcantly differentially expressed
RNAs were further explored using GeneSetDB (Araki et al., 2012) using all
genes represented in the control and DAZL immunoprecipitations as the
universe.
Site-directed mutagenesis
The R115G mutant DAZL overexpression construct was generated by
PCR of the R115G coding sequence from pMS2-hDAZL (Collier et al.,
2005) harbouring the R115G mutation (a gift from Prof. Nicola Gray),
which was introduced with the QuikChange Lightening Site-Directed
Mutagenesis kit (Agilent Technologies, Edinburgh, UK). The PCR product
was cloned into pCMV6-entry (referred to as vector only control)
(OriGene Technologies, Rockville, MD, USA) using SgfI and XhoI. The
mutant SMC1B 3′ untranslated region (3′UTR)-luciferase construct and
the mutant TEX11 3′UTR-luciferase construct were created by mutating G
in the mouse Dazl-binding site to A using the QuikChange Lightening Site-
Directed Mutagenesis kit (Agilent Technologies, Edinburgh, UK). A second
mutant SMC1B 3′UTR-luciferase construct was also created using site-
directed mutagenesis to delete the entire mouse Dazl-binding site. All con-
structs were conﬁrmed to be correct using an ABI 3730XL capillary Sanger
sequencing instrument.
Luciferase assays
HEK293T cells (human embryonic kidney cells) were cultured in DMEM +
GlutaMAX™ supplemented with 10% foetal bovine serum and maintained
at 37°C in 5% CO2. For the luciferase assays, cells were seeded at a dens-
ity of 20 000 cells per well of a 96-well plate. Cells were transfected with
1ng of the 3′UTR-luciferase construct (wildtype or mutant) or a 3′UTR-
luciferase empty vector control (Genecopoeia, Rockville, MD, USA),
plus 50 ng of either a wildtype DAZL overexpression construct, a R115G
mutant DAZL overexpression construct or a vector only control (OriGene
Technologies, Rockville, MD, USA), using TransIT-LT1 transfection reagent
(Mirus Bio, Cambridge, UK). Luciferase expression was detected 48 h post
transfection using the Luc-Pair Luciferase Assay Kit (Genecopoeia, Rockville,
MD, USA) according to manufacturer’s instructions.
Sucrose gradient analysis
HEK293T cells were transfected as described above. At 48 h post transfec-
tion, cells were treated with 150 µg/ml of cycloheximide before lysis in a
polysome lysis buffer (20 mM Hepes pH 7.6, 2 mM MgCl2, 150 mM KCl,
0.5% Nonidet P40, 2 mM dithiothreitol (DTT), 100 U/ml RNasin
(Promega, South Hampton, UK)), 150 µg/ml cycloheximide, 1× protease
inhibitor (Sigma Aldrich, Dorset, UK) and 1× Halt phosphatase inhibitor
(Thermo Fisher Scientiﬁc, Paisley, UK). The KCl concentration of the
lysates was adjusted before being loaded onto a 10-ml linear sucrose gradi-
ent (10–50%) containing 20 mM Hepes pH7.6, 2 mM MgCl2, 250 mM KCl,
0.5% Nonidet p40, 2.5 mM DTT and 0.5 µg/ml heparin. Gradients were
centrifuged for 120 min at 4°C in a Beckman SW41 Rotor at 181 781g.
Following centrifugation, 10 fractions of 1 ml were collected from the gra-
dient with a KD Scientiﬁc peristaltic pump (Holliston, MA, USA) and a
Foxy Jr® fraction collector (Teledyne Isco, Lincoln, NE, USA). Absorption
traces were recorded with a UA6 Absorbance Detector with an A254 ﬁlter
(Teledyne Isco, Lincoln, NE, USA). Fractions 1–2 and 6–10 were pooled,
respectively, for luciferase RNA analysis.
RNA extraction, cDNA synthesis and
quantitative RT-PCR
RNA from human foetal ovaries was extracted using the RNeasy Micro Kit
(Qiagen, Crawley, UK) according to manufacturer’s instructions. Cytoplasmic
RNA from luciferase-transfected HEK293T cells was extracted with the
Cytoplasmic and Nuclear RNA Puriﬁcation Kit (Norgen-Biotek, Ontario,
Canada) according to manufacturer’s instructions. RNA was precipitated
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from sucrose gradients using phenol–chloroform (Life Technologies, Paisley,
UK), 0.3 M sodium acetate and isopropanol. RNA was reverse transcribed
to cDNA using concentrated random primers and Superscript III reverse
transcriptase (Life Technologies) according to manufacturer’s instructions,
and the cDNA synthesis reaction was diluted appropriately before proceed-
ing. Primers for quantitative RT-PCR (RT-qPCR) were designed to amplify all
transcript variants and are exon-spanning. Primer pair efﬁciencies were calcu-
lated with the LinReg PCR applet (Ramakers et al., 2003). Each reaction was
performed in a ﬁnal volume of 10 µl, with 1× Brilliant III SYBR Green qPCR
Master Mix (Agilent, Santa Clara, CA, USA), 20 pmol of each primer and 2 µl
of diluted cDNA. Each cDNA sample was analysed in triplicate. For expression
analyses in human foetal ovary, target genes were normalised to the geometric
mean expression of B2M (Beta-2 microglobulin) and RPL32 (ribosomal protein
L32). For Luciferase expression, the Renilla sequence which was located on the
same construct was used for normalisation. Data analysis for relative quantiﬁca-
tion of gene expression and calculation of SDs was performed as outlined
(Livak and Schmittgen, 2001; Vandesompele et al., 2002).
RNA in situ hybridisation and
immunohistochemistry
Multiplex detection of SMC1B and DAZL protein was performed by Aquila
Histoplex, University of Edinburgh. RNA in situ hybridisation was carried out
using RNAscope® designed probes and reagents (Advanced Cell Diagnostics,
Hayward, CA, USA). Brieﬂy, slides were dewaxed and tissue permeabilised
with hydrogen peroxide, heat retrieval and proteinase K. RNA probes
(SMC1B or DapB (RNAscope® universal negative control)) were hybridised at
40°C for 2 h, followed by six ampliﬁcation steps to amplify the signal. For
detection, tissue was stained with FITC tyramide at 1:100 for 10min.
Immunohistochemistry was carried out using a mouse DAZL antibody (Abd
Serotec, Oxford, UK) at 1:200, a peroxidase secondary antibody at 1:200 and
Cy3 tyramide signal ampliﬁcation at 1:50; counterstained with DAPI.
Results
RNA immunoprecipitation and sequencing
identiﬁes novel RNA targets of DAZL
To discover novel and human DAZL targets in the human foetal ovary,
we carried out RNA-Seq after immunoprecipitation with foetal ovaries
at 17 weeks gestation, when many oocytes are in the early stages of
meiosis. Differential gene expression analysis identiﬁed a total of 764
RNAs that were signiﬁcantly enriched by DAZL immunoprecipitation
relative to the IgG control (FDR≤ 0.05 and log-fold change≥ 2) (see
Supplementary Table S1). Among these were validated RNA targets
of murine Dazl, SYCP3 and TEX14, indicating technical success.
We performed a gene set enrichment analysis using GeneSetDB
(Araki et al., 2012) to investigate whether any disease/phenotype or
gene ontology was overrepresented in our list of DAZL-bound RNAs
(FDR < 0.05)(Table I and Supplementary Table S2). The majority of
the disease/phenotypes that were enriched were related to germ
cells, meiosis, gamete production and infertility, but only in males,
which likely reﬂects the lack of female/ovary-related high-throughput
data available for enrichment analyses. The role of DAZL in gameto-
genesis was also evident in the gene ontologies, as the ontology mei-
osis was signiﬁcantly enriched (GO:0007126). Within this ontology,
the DAZL-enriched RNAs could be divided into different functional-
ities in meiosis such as synaptonemal complex formation (SYCP1,
SYCP3), cohesin formation (SMC1B, RAD21), spindle assembly check-
point (MAD2L1, TRIP13), and recombination and DNA repair
(HORMAD1, TRIP13, TEX11, RAD18, RAD51). The enrichment analysis
also highlighted the role DAZL targets may have in the mitotic cell
cycle (GO:0000278) and the G1/S transition (GO:0000082).
Given the well-established role of DAZL in meiosis (Saunders et al.,
2003), we decided to focus our investigation by identifying other RNA
targets of DAZL with meiotic roles in the human foetal ovary. SYCP1,
TEX11 and SMC1B, which represent RNAs from different meiotic
functions, were selected for further investigation (Supplementary Fig. S2).
We validated these novel RNA targets in vitro using RT-qPCR on a separ-
ate immunoprecipitation experiment to conﬁrm that DAZL can bind
these RNAs, and calculated the enrichment ratios for each target
(Supplementary Fig. S3). Furthermore, we assessed the abundance of ref-
erence genes RPL32 and GAPDH, and the granulosa cell marker FOXL2,
showing these were not enriched after DAZL immunoprecipitation, thus
highlighting the speciﬁcity of our RNA immunoprecipitation experiment.
DAZL and novel target RNA expression
across gestation
Expression of a selected number of novel meiotic RNA targets in the
human foetal ovary identiﬁed by DAZL immunoprecipitation was ana-
lysed across gestation, which was divided into three periods, including
........................................................................................
Table I Gene set enrichment analysis.
Class Set name FDR
Disease/
phenotype
Arrest of male meiosis 7.80E-06
Abnormal male meiosis 1.70E-03
Azoospermia 2.50E-03
Decreased testis weight 4.80E-03
Abnormal spermatocyte morphology 5.80E-03
Male infertility 5.90E-03
Small testis 6.80E-03
Male germ-cell apoptosis 7.30E-03
Testicular atrophy 8.10E-03
Abnormal apoptosis 1.70E-02
Abnormal synaptonemal complex 3.90E-02
Gene
ontology
Mitotic cell cycle (GO:0000278) 1.40E-04
G1/S transition of mitotic cell cycle
(GO:0000082)
2.50E-03
DNA repair (GO:0006281) 8.10E-03
Protein K63-linked ubiquitination
(GO:0070534)
1.70E-02
GTP catabolic process (GO:0006184) 1.70E-02
Protein K48-linked ubiquitination
(GO:0070936)
2.60E-02
Meiosis (GO:0007126) 2.60E-02
G1 phase of mitotic cell cycle (GO:0000080) 4.70E-02
Ubiquitin-dependent protein catabolic process
(GO:0006511)
4.80E-02
False discovery rate (FDR) is <0.05. For a list of RNAs associated with different
Subclasses, refer to Supplementary Table S2.
Enrichment of speciﬁc disease/phenotypes and gene ontologies was performed
using GeneSetDB (Araki et al., 2012).
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germ cells in mitosis before the onset of meiosis (8–9 wga), at the
commencement of meiosis (14–16 wga) and later in meiosis including
the onset of meiotic arrest and primordial follicle formation (17–20wga).
DAZL transcript levels dramatically increased at 14–16 wga, and contin-
ued to rise at 17–20wga (Fig. 1A). This pattern of expression across ges-
tation was also observed in RNAs that have a role in synaptonemal
complex formation (Fig. 1B), as well as with the meiotic cohesin SMC1B.
The expression of the mitotic cohesin RAD21, however, was highest at
8–9 wga and fell signiﬁcantly during gestation (Fig. 1C). Those RNAs
with functions in recombination and DNA repair showed two different
patterns of expression (Fig. 1D). TRIP13, HORMAD1 and TEX11 mim-
icked the expression trend observed for the other meiotic RNAs,
while RAD18 and RAD51 transcript levels dropped between 8–9 and
14–16 wga, but then increased again at 17–20 wga.
As chromosome cohesion is an example of a role not previously
associated with DAZL, we visualised expression of the meiotic cohe-
sin subunit SMC1B across gestation in relation to DAZL using RNA in
situ hybridisation for SMC1B with immunohistochemistry for DAZL
(Fig. 2). At all gestational ages examined, SMC1B RNA was exclusively
present in germ cells, and predominantly co-localised with DAZL pro-
tein, although there are areas of germ cells expressing neither, and a
few DAZL positive cells that lacked SMC1B were also identiﬁed. At
14 wga, SMC1B staining was punctate, with expression being mainly
located in the germ-cell cytoplasm; only a few germ cells showed
some nuclear staining. This changed at 16 wga, as SMC1B transcripts
were detected in markedly more germ cells. There was no signiﬁcant
difference in SMC1B expression between 16 wga and 19 wga, how-
ever in the 19 wga tissue, SMC1B staining appeared more punctate
again.
Stimulation of translation by DAZL via
3′UTR sequences
Previous investigations into the function of Dazl have shown this RNA-
binding protein to either stimulate (Reynolds et al., 2005; Reynolds
et al., 2007) or, more rarely, to repress (Chen et al., 2014) the transla-
tion of speciﬁc transcripts. To ascertain what translational effect DAZL
had on the selected targets SYCP1, TEX11 and SMC1B, representing
members of different functional groups, we used a 3′UTR-luciferase
reporter assay in HEK293T cells. All three novel RNA targets showed
signiﬁcantly increased luciferase activity in the presence of DAZL,
compared to the vector only control (Fig. 3). No stimulation of transla-
tion was observed with a GAPDH 3′UTR or in the absence of a 3′UTR,
indicating this effect is speciﬁc to the novel target 3′UTRs. The DAZL
R115G mutant, identiﬁed in a woman with spontaneous premature
ovarian failure (Tung et al., 2006b), has a signiﬁcantly impaired ability
to bind RNA, as the mutation is located within the DAZL RNA recog-
nition motif (RRM) (Jenkins et al., 2011). Expression of the R115G
mutant in HEK293T cells resulted in no increase in luciferase activity
compared with the vector only control for all the novel RNA targets
(Fig. 3). This indicates that the translation of SYCP1, TEX11 and SMC1B
is dependent on the RNA-binding ability of DAZL.
As the human DAZL-binding site has not been identiﬁed, we
mutated instances of the consensus mouse Dazl-binding site, i.e.
U(2–10)G/CU(2–10) (Venables et al., 2001) in these novel target 3′
UTR’s to elucidate whether DAZL is acting via this site in humans. To
do this, we mutated the G base to an A in SMC1B and TEX11, which
has previously been demonstrated to signiﬁcantly weaken DAZL bind-
ing (Venables et al., 2001). However, upon using these mutant 3′UTR
constructs in a luciferase reporter assay, we were unable to see a sig-
niﬁcant difference in the stimulation of translation in comparison to the
wildtype 3′UTR (Supplementary Fig. S4). In addition, we repeated this
assay using a mutant SMC1B 3′UTR-luciferase construct with deleted
mouse Dazl-binding sites, and were also unable to observe any signiﬁ-
cant differences (Supplementary Fig. S4).
As mRNA translation and mRNA stability are often linked, and
DAZL has been reported to mediate the stabilisation of HuB mRNA in
germ cells of zebraﬁsh embryos (Wiszniak et al., 2011), we examined
the steady-state levels of luciferase mRNA in the cytoplasm to deter-
mine whether the change in luciferase activity in the presence of
Figure 1 Selected RNA expression in the human foetal ovary across gestation. RNAs have been grouped into different functions based on published
literature (A–D); however, some RNAs have overlapping functions. Target gene expression has been normalised to the geometric mean expression of
RPL32 (ribosomal protein L32) and B2M (beta-2 microglobulin). Mean ± SEM, n = 5. *P < 0.02, **P < 0.002, ***P < 0.0002, ****P < 0.0001 by ANOVA.
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DAZL (Fig. 3) was a consequence of altered luciferase mRNA stability.
For each of the target mRNAs that showed a dependence on DAZL
for increased luciferase activity, there appeared to be no signiﬁcant
change in luciferase mRNA levels, as assessed by RT-qPCR, when
compared to the control (Fig. 4A), indicating a speciﬁc effect on
translation.
We complemented the mRNA stability analysis with polysome pro-
ﬁling to study the translational state (i.e. ribosome loading) of novel
target RNAs in the presence and absence of DAZL. We used the
3′UTR-luciferase reporter system with added cycloheximide to ‘freeze’
actively translating ribosomes on mRNAs (Fig. 4B). After ultracentrifuga-
tion to separate the cellular extracts into efﬁciently translated (ribosome
bound) and untranslated (ribosome free) RNAs, we used RT-qPCR to
calculate the proportion of luciferase RNA being translated. The propor-
tion of SYCP1, TEX11 and SMC1B luciferase RNA that was ribosome
bound was signiﬁcantly higher in the presence of DAZL (Fig. 4C) while
the control GAPDH 3′UTR mRNA was unaffected, suggesting this effect
is speciﬁc to the novel target 3′UTRs and conﬁrms the ability of DAZL
to stimulate the translation of these RNAs.
Discussion
We adopted a global approach combining the immunoprecipitation of
endogenous DAZL with RNA-sequencing technology to identify novel
transcripts bound by DAZL in the human foetal ovary, and identiﬁed
764 potential RNA targets of DAZL. Among these targets were RNAs
Figure 2 Localisation of SMC1BmRNA with DAZL in human foetal ovary, by RNA in situ hybridisation in combination with immunohistochemistry.
Columns show SMC1B (structural maintenance of chromosomes 1B) or DAZL (deleted in azoospermia-like), and merged images as indicated, with
the right hand column showing higher power images at the indicated gestations and negative controls. Arrows identify somatic cell streams.
Arrowheads identify germ-cell nests. Merge image; scale bar is 20 µm (the scale is the same for columns 1 and 2). Magniﬁed image; scale bar is 10 µm.
Figure 3 3′UTR-luciferase reporter assay. Increased luciferase
activity is observed for target RNAs, but not an empty 3′ untranslated
region (3′UTR) or GAPDH 3′UTR, in the presence of DAZL (blue bar)
relative to an empty vector control (magenta bar). No stimulation is
observed when the R115G DAZL mutant is overexpressed (green bar).
Fireﬂy luciferase signals were normalised to Renilla luciferase signals.
Mean ± SEM, n = 4, **P < 0.01 (Student’s t-test).
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involved in synaptonemal complex formation, including SYCP1. More
importantly, these data identiﬁed novel potential roles for DAZL func-
tion during early meiosis in the human oocyte, speciﬁcally in chromo-
some cohesion establishment, through regulation of targets including
SMC1B, and in DNA recombination, via targets including TEX11.
These are fundamental processes in determining oocyte quality and
whose establishment in foetal life may support lifelong fertility. We
report changes in the levels of a range of novel DAZL mRNA targets
across gestation in the human foetal ovary, over the period including
germ-cell mitosis, entry into meiosis and subsequent meiotic arrest
and follicle formation. Furthermore, using translation assays we
showed that DAZL stimulates translation of its novel targets SYCP1,
TEX11 and SMC1B (representing different meiotic processes) via their
3′UTRs. This effect was not seen using a DAZL mutant with impaired
RNA-binding activity, indicating that translation of these mRNAs is
indeed regulated by DAZL.
In order to understand the role of DAZL in fertility, several groups
have carried out investigations to identify in vivo mRNA targets of
DAZL. These inquiries have mainly relied on microarray analysis with
or without immunoprecipitation of recombinant/endogenous Dazl
from wildtype and Dazl−/− male mice (Jiao et al., 2002; Reynolds et al.,
2005). The limited information on the function of Dazl in the female
indicates that it is important in later stages of oocyte maturation
through zygote formation, where Dazl-dependent translation is
necessary for spindle assembly, the Metaphase I–II transition and early
embryo development (Chen et al., 2011). More recently, expression
proﬁling of the Dazl−/− mouse foetal ovary has identiﬁed 104 genes
expressed speciﬁcally in pre-meiotic to pachytene germ cells and the
use of single-cell, single-transcript measurements has demonstrated
that Dazl was required for the initial induction of nearly all identiﬁed
meiotic prophase genes (Soh et al., 2015), but whether the mRNA
transcripts of these genes were bound and/or translated by Dazl was
not investigated. Both these studies were conducted in mouse, and
no studies have addressed DAZL and its mRNA targets in human
female meiosis.
In this investigation, the limited availability of fresh human foetal
ovaries and the need to pool snap-frozen foetal ovaries to create a lys-
ate for immunoprecipitation precluded the use of CLIP-Seq (UV cross-
linking prior to immunoprecipitation and sequencing), currently the
gold standard for large-scale identiﬁcation of protein–RNA interac-
tions (Murigneux et al., 2013). While the potential for post-lysis associ-
ation of RNAs is a concern, Supplementary Fig. S2 shows no
enrichment of the reference RNAs GAPDH and RPL32, or the granulo-
sa cell marker FOXL2 with DAZL. Furthermore, our use of RNA in situ
hybridisation with immunohistochemistry conﬁrms that SMC1B is co-
localised with DAZL in germ cells. However, we cannot exclude the
possibility of post-lysis interactions between germ-cell expressed
mRNAs containing a DAZL-binding site and DAZL protein. In add-
ition, DAZL may bind different variations of its binding site with differ-
ent afﬁnities, and mRNAs containing low afﬁnity sites may be missed in
the absence of cross-linking.
Interestingly, only a few of the validated RNAs that have been previ-
ously identiﬁed as direct Dazl targets in mouse also appear in our
human data set; namely Sycp3 and Tex14 but not Tex19, Mvh or Tet1.
However, the majority of the previous work was done using testis, and
the differences we observe may reﬂect species differences (mouse ver-
sus human), but also possibly reﬂect the different requirements of
female and male germ cells. Indeed, there is some evidence of a sex-
dependent function of DAZL: the Dazl−/− phenotype can be partially
rescued by a human DAZL transgene in mouse testis, but not ovary
(Vogel et al., 2002). Additionally, several DAZL allelic variants have
been correlated with different phenotypic effects in men and women
(Tung et al., 2006b). In their study, Soh et al. (2015) identiﬁed 104
genes whose expression at the mRNA level during prophase is Dazl-
dependent (Soh et al., 2015). Intriguingly, a small number of these tran-
scripts, including SYCP1, TEX11 and SMC1B, were also identiﬁed in our
study. This indicates that full expression of a subset of genes may be
dependent on DAZL at two distinct stages: early on for initial induction
and accumulation of mRNA via a poorly understood DAZL activity (Lin
et al., 2008; Soh et al., 2015) and at a later stage for efﬁcient activation
Figure 4 (A) DAZL stimulates the translation of SYCP1, TEX11 and SMC1B. Quantitative RT-PCR of 3′UTR-luciferase expression shows that RNA
stability is not affected by the presence of DAZL. Mean ± SEM, n = 4. (B) Polysome proﬁles. With the use of cycloheximide, polysomes are ‘frozen’
on RNA and can be seen as small bumps in the trace. Polysomes are no longer present with EDTA. (C) Percentage of 3′UTR-luciferase RNA associated
with translating polysomes. In the presence of DAZL, the 3′UTRs of SYCP1 (synaptonemal complex protein-1), TEX11 (testis expressed 11) and
SMC1B were signiﬁcantly more ribosome bound than ribosome free, implicating DAZL in the translation of these targets. Mean ± SEM, n = 4–6. *P <
0.05, **P < 0.01 (Student’s t-test).
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of translation (Fig. 3), as previously demonstrated for mouse Dazl tar-
gets (Reynolds et al., 2005; Reynolds et al., 2007; Chen et al., 2011).
The human DAZL-binding element has yet to be elucidated, there-
fore we carried out analysis of the effect of mutating the mouse Dazl-
binding site in SMC1B and TEX11, but found that the speciﬁc mutations
we introduced, based on work by Venables et al. (2001), did not affect
the ability of DAZL to stimulate translation. However, a few RNAs
identiﬁed by our DAZL immunoprecipitation did not contain the mur-
ine Dazl-binding site, one of these being SYCP3, a major component of
the lateral elements of the synaptonemal complex in meiotic germ cells
(Schramm et al., 2011). This is intriguing given the evidence implicating
it as a direct Dazl target in mouse (Reynolds et al., 2007). In primordial
germ cells derived from human embryonic stem cells, overexpression
of DAZL resulted in the upregulation of SYCP3 and formation of syn-
aptonemal complexes, consistent with SYCP3 being a DAZL target in
human (Kee et al., 2009). Potentially, translational regulation of SYCP3
mRNA in humans occurs via a non-consensus DAZL-binding site
located in the 3′UTR, or regulation may occur indirectly through the
association of DAZL with a partner protein that is also an mRNA-
speciﬁc binding protein. A known example is DAZL associated
protein-1 (Tsui et al., 2000a; Smith et al., 2011). This may offer a pos-
sible explanation for the absence of a signiﬁcant effect of our Dazl-
binding site mutagenesis. While a detailed identiﬁcation and analysis of
the molecular interaction between DAZL and the novel targets identi-
ﬁed here is outwith the scope of this study, both these lines of evi-
dence indicate the need for such studies in the human.
These data conﬁrm the involvement of DAZL in synaptonemal
complex formation in humans through the translation of SYCP1, and
evidence suggests this may have important implications for lifelong
female fertility. SYCP1 is thought to function as a molecular frame-
work, which enables other proteins to attach and complete synapto-
nemal complex assembly and progression of recombination (Schramm
et al., 2011). Indeed, Sycp1 null mice of both sexes are infertile due to
germ-cell loss through apoptosis despite normal axial element forma-
tion and chromosome alignment (de Vries et al., 2005). Importantly,
these data also suggest novel roles for DAZL (which may be indirect)
during early meiosis in the foetal oocyte, namely in establishment of
chromosome cohesion through the regulation of SMC1B, and in DNA
recombination via TEX11. There are no previous data implicating DAZL
in the translation of RNAs with these functions, which are increasingly
recognised to be key pathways that underpin lifelong oocyte quality.
Recent data have highlighted the cohesin complex as a major contributor
to age-related aneuploidy. Mice that are deﬁcient in Smc1β show loss of
cohesion and aneuploidy in their oocytes (Gilliland and Hawley, 2005;
Hodges et al., 2005), while oocytes of older women have decreased
SMC1β (Tsutsumi et al., 2014) show an increased inter-kinetochore dis-
tance (Duncan et al., 2012) and increasingly show premature predivision
of sister chromatids (Handyside, 2012; Ottolini et al., 2015). Intriguingly,
the cohesion complex is also implicated in DNA repair (Watrin and
Peters, 2006). Similarly, mutations in TEX11 have been reported in infer-
tile men with non-obstructive azoospermia (Yang et al., 2015). Meiotic
arrest in these patients resembled the phenotype of Tex11−/− male mice
(Yang et al., 2008), which have spermatocytes with asynapsed chro-
mosomes and reduced cross-over formation, leading to apoptosis at
the pachytene stage of Prophase I. Thus, these data suggest the poten-
tial involvement of DAZL in the subsequent risk of age-dependent
aneuploidy through translational regulation of SMC1B in early meiosis,
and as well as through its regulation of several other factors of estab-
lished importance in synapsis and recombination.
Conclusion
The RNA-binding protein DAZL is well established as an important
regulator of germ-cell development in both male and female although
most data derive from studies of mouse testis. Here we have identiﬁed
764 potential RNA targets of DAZL in the human foetal ovary, and
conﬁrmed in translational assays that three of these, SYCP1, TEX11
and SMC1B are DAZL-dependent targets. Through regulation of these
RNAs, we have uncovered novel potential functions for DAZL in the
foetal oocyte, in establishment of chromosome cohesion and in DNA
recombination, in addition to roles in synaptonemal complex forma-
tion. Consequently, we suggest DAZL has a key role in regulating fun-
damental processes that underpin oocyte quality, which may in turn
inﬂuence a woman’s fertility and reproductive lifespan.
Supplementary data
Supplementary data are available at Molecular Human Reproduction
online.
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